TELA Bio (TELA) Projected to Post Quarterly Earnings on Thursday

TELA Bio (NASDAQ:TELA) is anticipated to announce its earnings results after the market closes on Thursday, March 20th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $23.17 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

TELA Bio Stock Performance

TELA opened at $2.43 on Tuesday. The company has a current ratio of 2.62, a quick ratio of 1.81 and a debt-to-equity ratio of 14.22. The company’s fifty day moving average price is $2.62 and its two-hundred day moving average price is $2.72. TELA Bio has a 1-year low of $2.18 and a 1-year high of $6.50. The company has a market cap of $95.71 million, a price-to-earnings ratio of -1.44 and a beta of 1.10.

About TELA Bio

TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.